Depressive Disorder, Treatment-Resistant

"Depressive Disorder, Treatment-Resistant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Descriptor ID	D061218
MeSH Number(s)	F03.600.300.388
Concept/Terms	Depressive Disorder, Treatment-Resistant Depressive Disorder, Treatment-Resistant Depressive Disorder, Treatment Resistant Depressive Disorders, Treatment-Resistant Disorder, Treatment-Resistant Depressive Disorders, Treatment-Resistant Depressive Treatment-Resistant Depressive Disorder Treatment-Resistant Depressive Disorders Refractory Depression Depression, Refractory Depressions, Refractory Refractory Depressions Therapy-Resistant Depression Depression, Therapy-Resistant Depressions, Therapy-Resistant Therapy Resistant Depression Therapy-Resistant Depressions Treatment Resistant Depression Depression, Treatment Resistant Depressions, Treatment Resistant Resistant Depression, Treatment Resistant Depressions, Treatment Treatment Resistant Depressions

Below are MeSH descriptors whose meaning is more general than "Depressive Disorder, Treatment-Resistant".

Psychiatry and Psychology [F]
Mental Disorders [F03]
Mood Disorders [F03.600]
Depressive Disorder [F03.600.300]
Depressive Disorder, Treatment-Resistant [F03.600.300.388]

Below are MeSH descriptors whose meaning is related to "Depressive Disorder, Treatment-Resistant".

Below are MeSH descriptors whose meaning is more specific than "Depressive Disorder, Treatment-Resistant".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Depressive Disorder, Treatment-Resistant" by people in this website by year, and whether "Depressive Disorder, Treatment-Resistant" was a major or minor topic of these publications.

Bar chart showing 7 publications over 5 distinct years, with a maximum of 2 publications in 2017 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2012	1	0	1
2016	1	0	1
2017	2	0	2
2020	1	1	2
2022	1	0	1

Below are the most recent publications written about "Depressive Disorder, Treatment-Resistant" by people in Profiles.

Deligiannidis KM, Clayton AH. Patient-Specific Considerations, the GABA Pathway, and New Clinical Trial Data on Neuroactive Steroids in MDD and PPD. J Clin Psychiatry. 2023 03 16; 84(Suppl 1).

View in: PubMed
Zandi PP, Morreale M, Reti IM, Maixner DF, McDonald WM, Patel PD, Achtyes E, Bhati MT, Carr BR, Conroy SK, Cristancho M, Dubin MJ, Francis A, Glazer K, Ingram W, Khurshid K, McClintock SM, Pinjari OF, Reeves K, Rodriguez NF, Sampson S, Seiner SJ, Selek S, Sheline Y, Smetana RW, Soda T, Trapp NT, Wright JH, Husain M, Weiner RD. National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy. J ECT. 2022 09 01; 38(3):159-164.

View in: PubMed
Fantasia HC. Esketamine Nasal Spray for Treatment-Resistant Depression. Nurs Womens Health. 2020 Jun; 24(3):228-232.

View in: PubMed
Sahib AK, Loureiro JRA, Vasavada MM, Kubicki A, Joshi SH, Wang K, Woods RP, Congdon E, Wang DJJ, Boucher ML, Espinoza R, Narr KL. Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder. Eur Neuropsychopharmacol. 2020 04; 33:89-100.

View in: PubMed
Holtzheimer PE, Husain MM, Lisanby SH, Taylor SF, Whitworth LA, McClintock S, Slavin KV, Berman J, McKhann GM, Patil PG, Rittberg BR, Abosch A, Pandurangi AK, Holloway KL, Lam RW, Honey CR, Neimat JS, Henderson JM, DeBattista C, Rothschild AJ, Pilitsis JG, Espinoza RT, Petrides G, Mogilner AY, Matthews K, Peichel D, Gross RE, Hamani C, Lozano AM, Mayberg HS. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry. 2017 11; 4(11):839-849.

View in: PubMed
Gurnani T, Khurshid KA. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study. Asian J Psychiatr. 2017 Oct; 29:112-113.

View in: PubMed
Scherrer JF, Salas J, Sullivan MD, Schneider FD, Bucholz KK, Burroughs T, Copeland L, Ahmedani B, Lustman PJ. The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med. 2016 10; 91:110-116.

View in: PubMed
Mathew SJ, Shah A, Lapidus K, Clark C, Jarun N, Ostermeyer B, Murrough JW. Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs. 2012 Mar 01; 26(3):189-204.

View in: PubMed

People

Explore

Similar Concepts

Top Journals